Abstract: Abstract: Abstract: Abstract: Abstract: In the present paper we correlate clinical data, as well as histopathological, immunohistochemical and molecular biology methods, with the occurrence of both forms of inflammatory bowel disease (IBD) i.e. ulcerative colitis and Crohn's disease. We found that patients with a history of Epstein-Barr virus (EBV) or cytomegalovirus (CMV) infections, as well as steroid treatment, had increased susceptibility to the development of IBD. The diagnosis of IBD was confirmed by histopathology. Previous infections by EBV and CMV, as well as M. tuberculosis, were proved by PCR-based techniques and in situ hybridization. We found PCR-proved latent viral infections in 30-50% of the IBD patients we studied. However, we were unable to prove the presence of viral antigens by immunohistochemistry for EBV or CMV. We found positive correlations between the presence of anti-CMV IgG, as well as PCR-positive results for M. tuberculosis with an ulcerative colitis diagnosis. Additionally, up to 80% of IBD patients used steroids, which was found to be correlated with a diagnosis of Crohn's disease. Our data may support the theory that IBD could be related to previous viral infections and the use of
Idiopathic inflammatory bowel disease (IBD) comprises two major forms: ulcerative colitis (UC) and Crohn's disease (CD). The diagnosis is based on clinical, radiological, endoscopic and histopathological studies. However, nowadays about 10-20% of colectomy specimens remain unclassified and are designated as 'undetermined colitis' [1] . Both diseases are recognized worldwide [2, 3] . Several attempts have been made to uncover a possible infectious agent as a cause of IBD. But to date, such efforts have failed to provide any suspected pathogen [2] [3] [4] [5] [6] . Moreover, several hypotheses, e.g. psychiatric or previous viral infections, on the pathogenesis of IBD have been taken into consideration [3] . The aim of the present study was to estimate if some infections more commonly found in immuno- Microbiological studies were carried out at the Department of Microbiology in Poznan. The study material consisted of swabs and resected intestinal specimens. Additionally, blood serum from IBD patients was obtained. DNA extraction from gut samples was performed by PCR-ELISA technique. Using Mycobacterium paratuberculosis PCR test, Mycobacterium avium subspecies paratuberculosis DNA was evaluated. EBV RNA was assessed using the in situ hybridization technique by evaluation of EBER-1 and EBER-2 molecules. CMV DNA was analyzed by nested-PCR in patients' serum. DNA isolated from a cell culture of a standardized strain was used as a control.
Histopathological assessment. Histopathological assessment. Histopathological assessment. Histopathological assessment. Histopathological assessment. Surgical samples were processed routinely for paraffin blocks and hematoxylin-eosin slides were prepared. Using standard criteria, the diagnosis of CD as well as UC, and other diseases (in controls) was made. Then, using representative (diagnostic) paraffin blocks, we carried out IHC studies for EBV (mouse anti--EBV LMP; clone CS.1-4., DAKO, cat. no. M0897, titer 1:100) and CMV (mouse anti-CMV; clones DDG9 and CCH2, DAKO, cat. no. N1537, ready-to-use) antigens.
Statistical analysis. Statistical analysis. Statistical analysis. Statistical analysis. Statistical analysis. Statistical analysis was done using Statistica v. 7.0 software. The normality of distribution of examined parameters was checked by histograms with Gausse curve. None of the examined parameters from studied groups (CD, CU, control) had normal distribution. Correlation matrices analysis were employed to assess the correlation between examined parameters. For data analysis, we used correlation matrices. For statistical significance, p < < 0.05 was assumed. R R R R Results and discussion esults and discussion esults and discussion esults and discussion esults and discussion
Analysis of duration of the disease showed average time up to 12 years of clinical history, before intestinal resection in the CD group. In other groups, average length of clinical history was: UC 5.8 years, control group 0.7 years (Table 1) . We found a history of tuberculosis in two UC patients (9.5%), three patients (27.3%) with CD and one (6.7%) in the control group. A history of mumps was recorded in four patients (19%) in the UC group, three (27.3%) in the CD group and five patients (33.3%) from the control group. The frequency of measles in the studied groups was 38.1%, 54.5% and 40%, in UC, and CD and controls, respectively (Table 1) . A history of the use of steroids or other immunosuppressive drugs was recorded only in UC and CD patients. A history of previous acute streptococcal pharyngitis was found in ten UC patients (47.6%), in six CD patients (54.5%) but only in three (20%) cases from the control group.
Diarrhea was present in all patients with UC, while blood in stool was found in 81%. The highest prevalence of ileus (63.6%) was in CD patients. In 66.7% of the control group we found blood in patients' stools. There were 11 emergency operations performed: six in patients with UC (28.6%) and five in patients with CD (45.5%); 36 operations were planned ahead of time, including 15 in patients with UC (71.4%), six with CD (54.5%), and all 15 (100%) cases in the control group. The localization of changes in the bowel was: colon in 85.7% of the UC group, small bowel in 45.5% of CD patients, and rectum in 66.7% of the control group. Details of patients' characteristics are presented in Table 1 .
Some recent reports have suggested that initiation of IBD is somehow obscure. However, cells of innate immunity produce cytokines essential for inflammatory reactions, as well as factors critical for the subsequent initiation of specific immunity. However, such data has been not consistently reproduced. In the present study, a clinical diagnosis of IBD, and a diagnosis of other bowel diseases, was confirmed by double independent pathological opinion in all studied patients. All cases in the CD and UC groups fulfilled the morphological criteria of IBD (Figure 1) . Additional studies revealed Mycobacterium avium subspecies paratuberculosis (MASP), with the highest percentage of positive results in the CD group -seven (63.6%) ( Table 2 ). There were no laboratory or clinical features of recent CMV infection (anti-CMV IgM was negative in all groups). But previous exposure to viral antigens, expressed by presence of anti-CMV IgG, was confirmed in 25% of patients with CD, and in more than 40% of both UC and controls. Using molecular biology tests, viral nucleic acids were found in some patients.
For CMV, the percentage of positive results was lower in CD and higher in both UC and control groups. For EBV, the lowest number of positive pa- www.fhc.viamedica.pl tients was found in the UC group and higher values were found in CD and controls (Table 2) . However, IHC for viral antigens for EBV or CMV were negative ( Figure 2) . Nowadays, one theory of IBD development is based on a 'dysbiosis' or 'disregulated' immune response leading to intestinal disease by altered innate and adaptive immunity with unlimited activation of immunological mechanisms of inflammation [7] .
It has been studied in animal and clinical models [7] . Such models have revealed abnormal expression of heat shock proteins (Hsp), cytokines, chemokines, growth factors as well as TNF and eicosanoids and other bioactive proteins in IBD cases [8] . But it remains an open question as to what else could be a potent predisposing factor to IBD development.
Powell et al. first reported a patient with UC and cytomegalic inclusion disease in 1961 [for review see 9] . According to recent epidemiological data, patients with severe steroid-resistant UC might be at particular risk for CMV infection [10] [11] [12] [13] . In our studies, anti-CMV IgG was confirmed in 41.7% and CMV DNA was positive in the serum of 53.3% of control patients aged 40-79. The reactivation of CMV is a consequence of cell-mediated impaired immunity T T T T Table 1 [14] . In some patients, CMV may coexist with other infectious agents (e.g. Cryptosporidium spp., Isospora belli, Herpes simplex types 1 and 2, Mycobacterium avium-intracellular) found within the bowel [9, 10, 12, 15] . According to previously published data, CMV infection was detected fairly frequently (21%) in the surgical specimens of UC, and such cases were steroid resistant [9, 15] . On the other hand, patients with severe, steroid-refractory and steroid-dependent IBD are usually treated with immunosuppressive agents, and such therapy might increase the risk of CMV infection [10] . In a retrospective, case-controlled study, CMV was detected by immunohistochemistry only in ten of 40 (25%) patients with refractory UC and in 2.5% of patients with non-refractory UC [16] . Other authors have suggested that the prevalence of CMV complicated UC is less common then severe steroid-refractive CD with CMV positive patients estimated between 11% and 36% of cases [17] . In our study, serum CMV DNA was found in nine (42.9%) UC patients and four (36.4%) CD patients. There were no laboratory or clinical features of recent CMV infection in our IBD cases. Anti-CMV IgM was negative in all groups. Anti-CMV IgG was confirmed in sev- Although in some cases we were able to prove a previous CMV infection by laboratory test or molecular biology techniques, we were unable to prove the presence of CMV antigens in the removed intestine nor in the local lymph nodes. Such findings support aforementioned suggestions [18] . However, it remains unclear whether CMV infection has an active role in IBD development, or whether it exists coincidentally [11, 15] . Spieker et al. suggested that productively and latently EBV-infected cells are detectable in many, but not all, cases of IBD, and are more frequently detectable in active UC than in CD or controls [19] . In our study, there were no clinical or histological features of EBV infection in studied cases. Previously published data on IBD patients has shown EBV latent or productive infection in tonsils but not in any intestinal epithelial cells [20] . The results of our study confirm that observation. We found that in the UC group patients were EBV positive in 35.8%, with 54.5% in CD cases. However, in IHC studies, the presence of viral antigens in intestine samples for EBV was negative. Overall, EBV is unlikely to play a role as an etiological agent in IBD.
Using clinical data and the results of laboratory tests, the following correlations were found. In the CD group, the history of previous acute Streptococcal pharyngitis correlated with a history of measles. Patients with a clinical presentation of disease as obstruction had no previous history of mumps, while those who suffered from vesico-urinary fistula tended to have mumps in their clinical record. Patients with UC tended to have a history of measles and mumps as well as acute Streptococcal pharyngitis. Such a tendency was also observed in controls, but not in CD patients. Moreover, we found that in UC and in controls, but not in the CD group, there was a correlation between features of CMV infection, MASP and measles infection. CD patients, distinctively, were found to be those with important steroid 361 361 361 361 361 R R R R Role of inflammation in bowel diseases ole of inflammation in bowel diseases ole of inflammation in bowel diseases ole of inflammation in bowel diseases ole of inflammation in bowel diseases Figure 3 . Figure 3 . Figure 3 . Figure 3 . www.fhc.viamedica.pl inflammatory reaction. Among such, there are more common viral infections in past history, as was proved in the present study. Specific immunologic alterations in IBD were attributed to NOD2/CARD15 mutations [3, 21] . Abnormal function of NOD2 might lead to altered bacterial killing and be eventually directly related to mucosal damage [22] . Moreover, , , , , recently additional indirect influence of mutation in the NOD2 gene through cytokine production has been postulated [22] . There were also described roles of TLR4 genes polymorphism and additionally such factors as IL-23R, cytokines (INF-g, TNF-a, TGF-b, IL-4, IL-5, IL-6, IL-12, IL-13, IL-17, IL-21, IL-22, IL-26, IL-27, IL-31, IL-32), local microflora, bacterial infection, tobacco smoking, oral contraceptives, and even mucosal integrity [21, 22] . All these factors play important roles in driving an inappropriate response of T cells (especially Th1, 2, and 17) to possible enterocolic infectious agent. An inadequately inhibited reaction leads to full-blown IBD. Recently, the number of molecules believed to be potentially important in IBD development has increased dramatically. It now includes IL-1, IL-2R, CAMS, addressins, defensins, flagellins, granulysins, selectins, claudins, annexins, guanilyns, laminins, intimins, aquaporins, microsins, adaptins, fibrillarins, syndecam-1, stromelysin, integrins, galanin-1, tropomyosin, FGF, EGF, permeability-enchancing factor, neurotrophins, survivins, ubiquitins and zonulins [3, 21] .
To sum up, we should look for a better understanding of polygenic and multifactor etiology of IBD, for instance at impaired patients' immunity, e.g. expressed by higher susceptibility to some fairly common infections or need for steroid therapy, as reflected in the history of our patients. R R R R References eferences eferences eferences eferences
